Literature DB >> 215348

Gel isoelectric focusing method for specific diagnosis of familial hyperlipoproteinemia type 3.

G R Warnick, C Mayfield, J J Albers, W R Hazzard.   

Abstract

We describe a gel isoelectric focusing procedure for resolving into at least five bands the arginine-rich protein of very-low-density lipoproteins, and use the method in diagnosis of hyperlipoproteinemia type 3. We find that deficiency of one band, designated E3, relative to E2, expressed as an E3/E2 ratio less than or equal to 0.3, is specifically associated with hyperlipoproteinemia type 3 as diagnosed by traditional criteria in a large family study. In addition, we used the procedure to test 47 referral samples with demonstrable beta-migrating very-low-density liproprotein grouped by very-low-density lipoprotein cholesterol/total triglyceride ratios of greater than or equal to 0.3, from 0.25 to 0.3, and less than 0.25. All 24 of the first group, three of six in the second, and only one of 17 in the third had E3/E2 ratios of less than or equal to 0.3. Also, two normolipidemic children, without detectable lipoprotein abnormalities but related to subjects with hyperlipoproteinemia type 3, had E3/E2 ratios of less than or equal to 0.3. Use of our procedure improves the specificity of diagnosis and allows sensitive detection of asymptomatic subjects who may be at risk of developing the disorder.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 215348

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  40 in total

1.  Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia.

Authors:  L Kłosiewicz-Latoszek; W B Szostak
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Clinical chemistry through Clinical Chemistry: a journal timeline.

Authors:  Robert Rej
Journal:  Clin Chem       Date:  2004-12       Impact factor: 8.327

3.  Inference of a molecular defect of apolipoprotein B in hypobetalipoproteinemia by linkage analysis in a large kindred.

Authors:  M Leppert; J L Breslow; L Wu; S Hasstedt; P O'Connell; M Lathrop; R R Williams; R White; J M Lalouel
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

4.  Severe type III hyperlipoproteinemia in two patients maintained on chronic hemodialysis.

Authors:  G Feussner; J Bommer; R Ziegler
Journal:  Klin Wochenschr       Date:  1990-01-19

5.  An erroneous apolipoprotein E-3 band in high density lipoprotein fractions.

Authors:  A V Rawlings; T Deegan
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

6.  High-density lipoprotein subpopulations as substrates for the transfer of cholesteryl esters to very-low-density lipoproteins.

Authors:  M A Lasunción; A Iglesias; N Skottová; E Orozco; E Herrera
Journal:  Biochem J       Date:  1990-09-01       Impact factor: 3.857

7.  Degradation of lipoproteins by human monocyte-derived macrophages. Evidence for two distinct processes for the degradation of abnormal very-low-density lipoprotein from subjects with type III hyperlipidaemia.

Authors:  A K Soutar; B L Knight
Journal:  Biochem J       Date:  1984-02-15       Impact factor: 3.857

8.  Radioimmunoassay studies of human apolipoprotein E.

Authors:  C B Blum; L Aron; R Sciacca
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

9.  Genetics of the apolipoprotein-E isoprotein system in man.

Authors:  A M Cumming; F W Robertson
Journal:  J Med Genet       Date:  1982-12       Impact factor: 6.318

10.  LNA-enhanced detection of single nucleotide polymorphisms in the apolipoprotein E.

Authors:  Nana Jacobsen; Joan Bentzen; Michael Meldgaard; Mogens Havsteen Jakobsen; Mogens Fenger; Sakari Kauppinen; Jan Skouv
Journal:  Nucleic Acids Res       Date:  2002-10-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.